Article contributed and authored by: Dr. Alex Young, NHS surgeon and founder of Virti It’s estimated by the World Health Organisation (WHO) that there are more than 2 million different kinds of medical devices in the global market, ranging from surgical instruments to wound care apparatus and diagnostic software. Without them, modern medical practice as […]
Featured Article
Addressing the challenge of patient recruitment for clinical trials with the help of NLP and data science
By Andrea
Article contributed by Avenga and authored by: Igor Kruglyak, Senior Advisor at the global IT service provider Avenga and a 35+ year veteran executive of global key development and deployment projects, and Michael DePalma, Founder and President of Pensare, LLC; Co-Founder of Hu-manity.co, The Human API. Holder of 3 US patents and a 2-time TED-speaker. Natural […]
White Papers
Fix Your Marketing Funnel
Attract in-market audiences, stop the leak of leads, and streamline engagement for optimal conversion Factors influencing buyer behavior have … FREE Download

HCPs Want to Hear from You
Marketers may be relying on the tried and true direct sales model, only to be frustrated and unable to deliver results. Why are traditional marketing … FREE Download
Industry News
UCB expands partnership with Microsoft to speed up drug development
Belgium-based biopharmaceutical firm UCB has expanded its collaboration with technology company Microsoft to accelerate discovery and development of drugs for people living with severe diseases in immunology and The post UCB expands partnership with Microsoft to speed up drug development appeared … [Read More...]
ViiV Healthcare seeks USFDA approval to expand Cabenuva use for HIV-1 infected adults
Specialist HIV company ViiV Healthcare has submitted a supplemental new drug application (sNDA) to the US Food and Drug Administration (FDA) to expand the use of Cabenuva. Cabenuva The post ViiV Healthcare seeks USFDA approval to expand Cabenuva use for HIV-1 infected adults appeared first on … [Read More...]
USFDA accepts priority review for Pfizer’s TicoVac
Pharmaceutical company Pfizer has announced that the US Food and Drug Administration (FDA) has accepted its Biologics License Application (BLA) for priority review for TicoVac, a tick-borne encephalitis The post USFDA accepts priority review for Pfizer’s TicoVac appeared first on Pharmaceutical … [Read More...]
AstraZeneca withdraws Imfinzi indication in US for bladder cancer
AstraZeneca has voluntarily withdrawn the Imfinzi (durvalumab) indication for adult patients who received treatment earlier in the US for locally advanced or metastatic bladder cancer. The company has The post AstraZeneca withdraws Imfinzi indication in US for bladder cancer appeared first on … [Read More...]